Rexahn Pharmaceuticals, Inc. (REXN)

[jaytea]

RNN presentation today .. .

ROCKVILLE, Md., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter D. Suzdak, PhD, the Company's Chief Executive Officer, will present at the Oppenheimer 25th Annual Healthcare Conference. The presentation will be on Wednesday, December 10, at 10:55AM EST. An audio webcast and presentation for this conference will be available on the Company's website at www.rexahn.com in the Investor Relations section under 'Events and Presentations'. The conference will be held December 10 to 11, 2014, at the Crowne Plaza Hotel in New York.